Results 1 to 10 of about 5,876 (175)

Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion [PDF]

BMC Cardiovascular Disorders, 2002
BACKGROUND: GPIIb/IIIa inhibitors abciximab and eptifibatide have been shown to inhibit platelet aggregation in ischemic heart disease. Our aim was to test the efficacy of abiciximab (Reo Pro) or eptifibatide (Integrilin) alone or in combination with ...
Bertuglia, Silva, Giusti, Andrea
core   +4 more sources

Administration of eptifibatide as rescue therapy during mechanical thrombectomy in acute ischemic stroke. [PDF]

Front Neurol
BackgroundThe success of the technical implementation of mechanical thrombectomy (MT) depends on many factors. Considering the experience of the interventional radiologist and the anatomical vascular differences of individual patients, it has technical ...
Cernik D, Neumann J, Neradova J, Hlinena V, Viglas P, Cihlar D, Cihlar F.   +6 more
europepmc   +2 more sources

Protective effects of combined eptifibatide and ticagrelor in patients with unstable angina undergoing percutaneous coronary intervention: a single-center experience. [PDF]

BMC Cardiovasc Disord
Background We evaluated the safety and effectiveness of combined eptifibatide and ticagrelor in patients with unstable angina pectoris undergoing percutaneous coronary intervention (PCI).
Shi S, Ling Z, Gu S, Jiang T, Ling L.
europepmc   +2 more sources

Comparative Effects of Glenzocimab and Eptifibatide on Bleeding Severity in 2 Mouse Models of Intracranial Hemorrhage. [PDF]

J Am Heart Assoc
Background Antiplatelet drugs represent potential candidates for protecting the penumbral microcirculation during cerebral ischemia and improving the benefits of arterial recanalization in ischemic stroke.
Dupont S, Lebas H, Mavouna S, Pascal E, Perrot A, Cogo A, Bourrienne MC, Farkh C, Solo Nomenjanahary M, Ollivier V, Zemali F, Nieswandt B, Loyau S, Jandrot-Perrus M, Camerer E, Desilles JP, Mazighi M, Boulaftali Y, Ho-Tin-Noé B.   +18 more
europepmc   +2 more sources

Eptifibatide bolus dose postductal stenting intervention: A single-center experience. [PDF]

Ann Pediatr Cardiol
Objectives: Stent thrombosis, a potential complication of ductal stenting, is associated with high mortality. This is a catastrophic complication, which can occur acutely (within 24 h), subacutely (within 30 days), or late (≥30 days) after stent ...
Mehta R, Chattopadhyay A, Mukherji A, Ghosh S, Das JN, Gupta P.   +5 more
europepmc   +2 more sources

A woman with eptifibatide (integrilin)-induced thrombocytopenia following treatment of a clot in her coronary artery: A case report and literature review. [PDF]

Clin Case Rep
Eptifibatide, a GPIIb/IIIa receptor inhibitor, has shown its efficacy and safety in patients with high clot burden in their coronary vessels. It is widely used in patients with this condition.
Safi M, Nazari R, Senobari N, Taheri H, Ebrahimi P.   +4 more
europepmc   +2 more sources

Acute Profound Thrombocytopenia Induced by Eptifibatide Causing Diffuse Alveolar Hemorrhage

Case Reports in Critical Care, 2021
Background. Eptifibatide is a glycoprotein IIb/IIIa (GP IIb/IIIa) receptor inhibitor which prevents platelet activation. The mechanism in which eptifibatide causes profound thrombocytopenia is poorly understood. One hypothesis suggests antibody-dependent
Gregory Byrd, Sabina Custovic, David Byrd, Deanna Ingrassia Miano, Jasdeep Bathla, Antonious Attallah   +5 more
doaj   +1 more source

Results of a pilot clinical trial of the safety and efficacy of an original glycoprotein IIb/IIIa receptor inhibitor in acute coronary syndrome

Кардиоваскулярная терапия и профилактика, 2023
Aim. To study the safety and efficacy of Angipure in acute ST-segment elevation coronary syndrome (STE-ACS) and high-risk percutaneous transluminal coronary angioplasty (PTCA) compared with eptifibatide.Material and methods.
S. V. Lukyanov, Yu. F. Glukhov, E. V. T., B. M. Tankhilevich, D. A. Zateyshchikov, T. V. Khlevchuk, I. B. Bondareva   +6 more
doaj   +1 more source

Application of eptifibatide injection in acute ischemic cerebrovascular disease [PDF]

Xin yixue, 2022
Objective To evaluate the treatment effectiveness and safety of eptifibatide injection in the treatment of acute ischemic cerebrovascular disease （ICVD）.
Mei Ni, Tian Liang
doaj   +1 more source

Effects of two different glycoprotein platelet IIb/IIIa inhibitors and the clinical endpoints in patients with intracranial Pipeline flow diverter implant

Journal of Interventional Medicine, 2020
Objective: To compare the antiplatelet effect and major adverse cerebrovascular events of Pipeline for intracranial aneurysms using glycoprotein IIb/IIIa antagonists (GPI) eptifibatide and tirofiban.
Qiao Deng, Shichao Zhang, Mingzhou Li, Guozhong Zhang, Wenfeng Feng   +4 more
doaj   +1 more source